98%
921
2 minutes
20
Background: This study investigated medication adherence and related factors in adolescent kidney transplant recipients receiving immunosuppressive drugs.
Methods: Between February and October 2023, 115 adolescent kidney transplant recipients were selected through convenience sampling from follow-up centers in four Chinese tertiary hospitals. The study assessed medication adherence and influencing factors via a general information questionnaire, an adherence assessment scale, a medication belief scale, and an overall happiness scale.
Results: The average medication adherence score was 4.98 ± 2.32 points, with 60.08% (76/115) showing poor adherence. Five of these patients experienced graft failure, resulting in a 6.5% failure rate. No cases of graft failure occurred in those with excellent compliance. Univariate analysis revealed no significant differences in adherence based on sex, age, income, or education (p > 0.05). However, statistically significant differences in medication adherence were observed based on rejection reactions and infections (p < 0.01). Pearson's correlation analysis revealed that higher perceived medication necessity and overall happiness scores were correlated with better adherence (p < 0.05). Linear regression revealed that post-transplant rejection, infections, perceived medication necessity, and overall happiness significantly impacted adherence (p < 0.05).
Conclusion: The high prevalence of poor medication adherence among adolescent kidney transplant recipients highlights the importance for healthcare professionals to focus on monitoring significant post-transplant complications, improving recipients' understanding of the necessity of their medications, and evaluating their overall psychological well-being. Introducing an effective early warning system during home follow-up periods can enable timely interventions to improve medication adherence.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12141775 | PMC |
http://dx.doi.org/10.1111/petr.70103 | DOI Listing |
J Crohns Colitis
September 2025
Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Background & Aims: Pregnancy can be a complex and risk-filled event for women with inflammatory bowel disease (IBD). High-quality studies in this population are lacking, with limited data on medications approved to treat IBD during pregnancy. For patients, limited knowledge surrounding pregnancy impacts pregnancy rates, medication adherence, and outcomes.
View Article and Find Full Text PDFClin Ther
September 2025
Avadel Pharmaceuticals, Chesterfield, Missouri.
Purpose: Narcolepsy is a chronic neurologic disorder characterized by excessive daytime sleepiness (EDS) and can occur with or without cataplexy. Once-nightly sodium oxybate (ON-SXB) is approved for the treatment of cataplexy or EDS in patients 7 years of age or older with narcolepsy. ON-SXB contains both immediate-release and pH-dependent, controlled-release granules designed to be reconstituted in water and administered orally once at bedtime.
View Article and Find Full Text PDFVaccine
September 2025
Department of Psychology, University of Miami, Coral Gables, FL, USA. Electronic address:
Existing inequities are exacerbated during the COVID-19 pandemic. Similar to HIV, COVID-19 disproportionately affects Black and other communities of color. Among Black women living with HIV (BWLWH) this study examined the relationship between community level and individual level social determinants of health and time to COVID-19 vaccine uptake.
View Article and Find Full Text PDFJ Pharm Pract
September 2025
Department of Pharmacy, Guthrie Robert Packer Hospital, Sayre, PA, USA.
Telehealth in the ICU (Tele-ICU) may improve patient outcomes and optimize utilization of high acuity intensive care unit (ICU) beds. However, the relationship between tele-ICU and medication regimen complexity-ICU (MRC-ICU) score is unexplored. To assess the effect of tele-ICU on MRC-ICU score and describe pharmacists' work.
View Article and Find Full Text PDFObes Surg
September 2025
Department of Minimally Invasive Digestive Surgery, Antoine Béclère Hospital, AP-HP, 157 Rue de La Porte de Trivaux, 92141 Clamart, Clamart, France.
Background: Bariatric surgery (BS) is the most effective treatment for severe obesity, but a significant proportion of patients experience insufficient weight loss (IWL) or weight regain. Glucagon-like peptide-1 receptor agonists (arGLP-1) have emerged as a promising adjunctive therapy for managing these suboptimal outcomes. This study evaluates the efficacy and safety of arGLP-1 in patients with IWL or WR after BS.
View Article and Find Full Text PDF